Labcorp enhances cell and gene therapy development support through collaboration with xcell biosciences

Burlington, n.c.--(business wire)--labcorp (nyse: lh), a leading global life sciences company, is collaborating with xcell biosciences, inc. (xcellbio), a leading developer of cell and gene therapy technologies, to advance critical work that helps clients effectively bring innovative cell and gene therapies to market. through their collaboration, labcorp and xcellbio will work on a series of projects focused on improving the safety and efficacy of cell and gene therapies (cgts). this strengthen
LH Ratings Summary
LH Quant Ranking